These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7911728)

  • 21. MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment.
    Schneider JS
    J Neurosci Res; 1992 Jan; 31(1):112-9. PubMed ID: 1613817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Vaglini F; Pardini C; Cavalletti M; Maggio R; Corsini GU
    Brain Res; 1996 Nov; 741(1-2):68-74. PubMed ID: 9001706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of glia-conditioned medium on dopamine neurons in culture. Modulation of apoptosis, tyrosine hydroxylase expression and 1-methyl-4-phenylpyridinium toxicity.
    Mena MA; Casarejos MJ; García de Yébenes J
    J Neural Transm (Vienna); 1999; 106(11-12):1105-23. PubMed ID: 10651107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tyrosine hydroxylase mRNA expression by dopaminergic neurons in culture: effect of 1-methyl-4-phenylpyridinium treatment.
    Beck KD; Knusel B; Pasinetti G; Michel PP; Zawadzka H; Goldstein M; Hefti F
    J Neurochem; 1991 Aug; 57(2):527-32. PubMed ID: 1677030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.
    Kastner A; Herrero MT; Hirsch EC; Guillen J; Luquin MR; Javoy-Agid F; Obeso JA; Agid Y
    Ann Neurol; 1994 Aug; 36(2):206-14. PubMed ID: 7914399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GM1 ganglioside enhances Ret signaling in striatum.
    Newburn EN; Duchemin AM; Neff NH; Hadjiconstantinou M
    J Neurochem; 2014 Aug; 130(4):541-54. PubMed ID: 24821093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopaminergic dysfunction in neonatal hypothyroidism: differential effects of GM1 ganglioside.
    Vaccari A; Stefanini E; de Montis G; Rossetti ZL
    Neuropharmacology; 1990 Dec; 29(12):1161-9. PubMed ID: 2149873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain-derived neurotrophic factor selectively rescues mesencephalic dopaminergic neurons from 2,4,5-trihydroxyphenylalanine-induced injury.
    Skaper SD; Negro A; Facci L; Dal Toso R
    J Neurosci Res; 1993 Mar; 34(4):478-87. PubMed ID: 8097267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic treatment with GM1 ganglioside improves survival and function of cryopreserved embryonic midbrain grafted to the 6-hydroxydopamine-lesioned rat striatum.
    Sautter J; Höglinger GU; Oertel WH; Earl CD
    Exp Neurol; 2000 Jul; 164(1):121-9. PubMed ID: 10877922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of lesions and ganglioside GM1 treatment on striatal polyamine levels and nigral DA neurons. A role of putrescine in the neurotropic activity of gangliosides.
    Agnati LF; Fuxe K; Zini I; Davalli P; Corti A; Calza L; Toffano G; Zoli M; Piccinini G; Goldstein M
    Acta Physiol Scand; 1985 Aug; 124(4):499-506. PubMed ID: 2864781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia-induced neurotransmitter deficits in neonatal rats are partially corrected by exogenous GM1 ganglioside.
    Hadjiconstantinou M; Yates AJ; Neff NH
    J Neurochem; 1990 Sep; 55(3):864-9. PubMed ID: 1696622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ganglioside GM1 cooperates with brain-derived neurotrophic factor to protect dopaminergic neurons from 6-hydroxydopamine-induced degeneration.
    Fadda E; Negro A; Facci L; Skaper SD
    Neurosci Lett; 1993 Sep; 159(1-2):147-50. PubMed ID: 8264958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. tGS ganglioside induces peculiar morphological features in grafted dopaminergic cells and promotes motor recovery in rats with unilateral lesions in the nigrostriatal dopamine pathway.
    Nishino H; Hashitani T; Isobe Y; Furuyama F; Sato H; Kumazaki M; Horikomi K; Awaya A
    Brain Res; 1990 Nov; 534(1-2):73-82. PubMed ID: 1981486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between NMDA receptor expression and MPP+ toxicity in cultured dopaminergic cells.
    Church WH; Hewett SJ
    J Neurosci Res; 2003 Sep; 73(6):811-7. PubMed ID: 12949907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans.
    Wu G; Lu ZH; Kulkarni N; Ledeen RW
    J Neurosci Res; 2012 Oct; 90(10):1997-2008. PubMed ID: 22714832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of 1-methyl-4-phenylpyridinium ion (MPP+) on catecholamine levels and activity of related enzymes in clonal rat pheochromocytoma PC12h cells.
    Naoi M; Takahashi T; Nagatsu T
    Life Sci; 1988; 43(18):1485-91. PubMed ID: 2903426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of GM1 ganglioside treatment on the recovery of dopaminergic nigro-striatal neurons after different types of lesion.
    Toffano G; Agnati LF; Fuxe K; Aldinio C; Consolazione A; Valenti G; Savoini G
    Acta Physiol Scand; 1984 Nov; 122(3):313-21. PubMed ID: 6151339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response of the damaged dopamine system to GM1 and semisynthetic gangliosides: effects of dose and extent of lesion.
    Schneider JS; Distefano L
    Neuropharmacology; 1995 May; 34(5):489-93. PubMed ID: 7566482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential recovery of dopamine synthetic enzymes following MPTP and the consequences of GM1 ganglioside treatment.
    Hadjiconstantinou M; Neff NH
    Eur J Pharmacol; 1990 May; 181(1-2):137-9. PubMed ID: 1974854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. siRNA-mediated knockdown of B3GALT4 decreases GM1 ganglioside expression and enhances vulnerability for neurodegeneration.
    Verma M; Schneider JS
    Mol Cell Neurosci; 2019 Mar; 95():25-30. PubMed ID: 30611881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.